Alfred L Ochs1,2, David E Ross1,3, Megan D Zannoni1, Tracy J Abildskov4, Erin D Bigler4,5. 1. Virginia Institute of Neuropsychiatry, Midlothian, VA. 2. Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA. 3. Department of Psychiatry, Virginia Commonwealth University, Richmond, VA. 4. Department of Psychology and Neuroscience Center, Brigham Young University, Provo, UT. 5. Department of Psychiatry and The Brain Institute of Utah, University of Utah, Salt Lake City, UT.
Abstract
PURPOSE: To examine intermethod reliabilities and differences between FreeSurfer and the FDA-cleared congener, NeuroQuant, both fully automated methods for structural brain MRI measurements. MATERIALS AND METHODS: MRI scans from 20 normal control subjects, 20 Alzheimer's disease patients, and 20 mild traumatically brain-injured patients were analyzed with NeuroQuant and with FreeSurfer. Intermethod reliability was evaluated. RESULTS: Pairwise correlation coefficients, intraclass correlation coefficients, and effect size differences were computed. NeuroQuant versus FreeSurfer measures showed excellent to good intermethod reliability for the 21 regions evaluated (r: .63 to .99/ICC: .62 to .99/ES: -.33 to 2.08) except for the pallidum (r/ICC/ES = .31/.29/-2.2) and cerebellar white matter (r/ICC/ES = .31/.31/.08). Volumes reported by NeuroQuant were generally larger than those reported by FreeSurfer with the whole brain parenchyma volume reported by NeuroQuant 6.50% larger than the volume reported by FreeSurfer. There was no systematic difference in results between the 3 subgroups. CONCLUSION: NeuroQuant and FreeSurfer showed good to excellent intermethod reliability in volumetric measurements for all brain regions examined with the only exceptions being the pallidum and cerebellar white matter. This finding was robust for normal individuals, patients with Alzheimer's disease, and patients with mild traumatic brain injury.
PURPOSE: To examine intermethod reliabilities and differences between FreeSurfer and the FDA-cleared congener, NeuroQuant, both fully automated methods for structural brain MRI measurements. MATERIALS AND METHODS: MRI scans from 20 normal control subjects, 20 Alzheimer's diseasepatients, and 20 mild traumatically brain-injuredpatients were analyzed with NeuroQuant and with FreeSurfer. Intermethod reliability was evaluated. RESULTS: Pairwise correlation coefficients, intraclass correlation coefficients, and effect size differences were computed. NeuroQuant versus FreeSurfer measures showed excellent to good intermethod reliability for the 21 regions evaluated (r: .63 to .99/ICC: .62 to .99/ES: -.33 to 2.08) except for the pallidum (r/ICC/ES = .31/.29/-2.2) and cerebellar white matter (r/ICC/ES = .31/.31/.08). Volumes reported by NeuroQuant were generally larger than those reported by FreeSurfer with the whole brain parenchyma volume reported by NeuroQuant 6.50% larger than the volume reported by FreeSurfer. There was no systematic difference in results between the 3 subgroups. CONCLUSION: NeuroQuant and FreeSurfer showed good to excellent intermethod reliability in volumetric measurements for all brain regions examined with the only exceptions being the pallidum and cerebellar white matter. This finding was robust for normal individuals, patients with Alzheimer's disease, and patients with mild traumatic brain injury.
Authors: Michelle M Miller-Thomas; Adam L Sipe; Tammie L S Benzinger; Jonathan McConathy; Sarah Connolly; Katherine E Schwetye Journal: Radiographics Date: 2016 Jul-Aug Impact factor: 5.333
Authors: Kacie L Wright; Ramona O Hopkins; Frank E Robertson; Erin D Bigler; H Gerry Taylor; Kenneth H Rubin; Kathryn Vannatta; Terry Stancin; Keith Owen Yeates Journal: J Neurotrauma Date: 2020-05-15 Impact factor: 5.269
Authors: Julija Stelmokas; Lance Yassay; Bruno Giordani; Hiroko H Dodge; Ivo D Dinov; Arijit Bhaumik; K Sathian; Benjamin M Hampstead Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Paul M Thompson; Ole A Andreassen; Alejandro Arias-Vasquez; Carrie E Bearden; Premika S Boedhoe; Rachel M Brouwer; Randy L Buckner; Jan K Buitelaar; Kazima B Bulayeva; Dara M Cannon; Ronald A Cohen; Patricia J Conrod; Anders M Dale; Ian J Deary; Emily L Dennis; Marcel A de Reus; Sylvane Desrivieres; Danai Dima; Gary Donohoe; Simon E Fisher; Jean-Paul Fouche; Clyde Francks; Sophia Frangou; Barbara Franke; Habib Ganjgahi; Hugh Garavan; David C Glahn; Hans J Grabe; Tulio Guadalupe; Boris A Gutman; Ryota Hashimoto; Derrek P Hibar; Dominic Holland; Martine Hoogman; Hilleke E Hulshoff Pol; Norbert Hosten; Neda Jahanshad; Sinead Kelly; Peter Kochunov; William S Kremen; Phil H Lee; Scott Mackey; Nicholas G Martin; Bernard Mazoyer; Colm McDonald; Sarah E Medland; Rajendra A Morey; Thomas E Nichols; Tomas Paus; Zdenka Pausova; Lianne Schmaal; Gunter Schumann; Li Shen; Sanjay M Sisodiya; Dirk J A Smit; Jordan W Smoller; Dan J Stein; Jason L Stein; Roberto Toro; Jessica A Turner; Martijn P van den Heuvel; Odile L van den Heuvel; Theo G M van Erp; Daan van Rooij; Dick J Veltman; Henrik Walter; Yalin Wang; Joanna M Wardlaw; Christopher D Whelan; Margaret J Wright; Jieping Ye Journal: Neuroimage Date: 2015-12-04 Impact factor: 6.556
Authors: Jamila Ahdidan; Cyrus A Raji; Edgar A DeYoe; Jedidiah Mathis; Karsten Ø Noe; Jens Rimestad; Thomas K Kjeldsen; Jesper Mosegaard; James T Becker; Oscar Lopez Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472